Bio-Nano Sensium Technologies, a subsidiary of Advance Nanotech, Inc., today announced a limited beta test program of its wireless biosensor system. Under terms of the program, beta-stage versions of Bio-Nano Sensium (BNS) system will be available to potential partners and customers for evaluation. Wireless biosensors are increasingly seen as a desirable treatment for a range of chronic conditions including diabetes, cardiac conditions and asthma.
The BNS system is based on a ground-breaking low-cost, disposable integrated sensor interface chip - the Sensium - that, due to its ultra low power and very small battery size, can be implanted in or worn on the body with complete freedom of movement unlike existing bulky monitoring solutions. The Sensium is compatible with a wide range of sensors and can be configured to detect vital signs such as ECG, blood oxygen and glucose, body temperature, and even motion and mobility. The BNS system is designed to enhance the way doctors and patients monitor a host of chronic illnesses, increasing the effectiveness of available treatments and improving the quality of life for patients.
The company's beta program serves a dual purpose. For prospective customers, the program offers the opportunity evaluate a working model of the BNS system. For BNS and Advance Nanotech partners and system integrators, the beta program provides a working platform for obtaining configuration data, developing control and calibration algorithms for bio-nano sensors, and optimizing wireless operating protocols for specific applications. Trials of the fully integrated BNS system are planned for the second quarter of 2006.
"As BNS technology becomes commercially available we anticipate a wide range of applications across the healthcare industry. Some of these applications will be developed by BNS and Advance Nanotech, others will be developed in partnership with outside organizations," said Stephanie Interbartolo, Senior Vice-President of Business Development for Advance Nanotech. "We encourage collaboration, and welcome the chance to demonstrate the technology to potential partners."
Bio-Nano Sensium Technologies is a joint venture between Advance Nanotech, Inc. and Toumaz Technology Ltd., a UK-based developer of advanced radio frequency (RF), analog and mixed signal semiconductors. The BNS technology holds great promise for integration in bio-nanosystems, where final product devices must be small, low-power, possess on-board processing capability and incorporate wireless communications.
